Skip to main content
. 2022 Jan 18;14(3):427. doi: 10.3390/nu14030427

Table 5.

Anthropometry Data for Participants with a BMI > 25 – < 30 kg/m2.

Active Placebo
Baseline Month 3 Month 6 Baseline Month 3 Month 6
WC (cm) 98.6 ± 9.0 96.1± 9.7 # 95.0 ± 10.2 *#† 101.8 ± 11.1 99.4 ± 11.1 # 99.8 ± 11.2#
HC (cm) 112.8 ± 7.2 110.5 ± 8.0 # 109.7 ± 8.1 *#† 114.7 ± 7.3 112.6 ± 6.8# 112.5 ± 7.05 #
Weight (kg) 85.5 ± 10.3 82.7 ± 10.5 *#† 81.9 ± 10.9 *#† 87.8 ± 13.4 86.1 ± 14.0 # 85.83 ± 14.02 #
Weight loss (%) −3.3 ± 3.7 #† −4.2 ± 5.2 #* −2.1 ± 3.4 −2.3 ± 4.0 #
BMI (kg/m2) 28.8 ± 1.4 28.0 ± 1.8 #† 27.7 ± 2.1 *#† 28.9 ± 1.2 28.4 ± 1.6 # 28.3 ± 1.7 #
Lean Mass (kg) 51.0 ± 9.1 50.0 ± 8.0 50.1 ± 8.3 52.9 ± 11.6 52.7 ± 11.6 52.8 ± 11.7
FM (kg) 32.5 ± 6.3 30.6 + 6.7 # 29.9 ± 7.0 # 33.2 ± 8.0 31.5 ± 8.3 # 31.0 ± 8.5 #
FM Arm (kg) 3.9 ± 1.2 3.7 ± 0.9 3.7 ± 1.0 3.8 ± 1.0 3.6 ± 1.0 3.6 ± 1.0
FM Leg (kg) 12.2 ± 3.2 11.7 ± 3.1 11.8 ± 3.9 # 12.4 ± 3.9 11.4 ± 4.0 11.4 ± 3.7 #
FM abdominal (trunk) (kg) 15.6 ± 3.5 14.4 ± 3.8 # 14.0 ± 3.8 *#† 16.2 ± 4.5 15.3 ± 4.6 # 15.1 ± 4.6 #
Android Fat (kg) 3.6 ± 2.0 2.6 ± 1.1 # 2.5 ± 1.0 # 3.8 ± 2.0 3.1 ± 1.5 3.0 ± 1.5 #
Gynoid Fat (kg) 7.3 ± 3.8 5.4 ± 1.5 # 5.3 ± 1.6 # 7.5 ± 3.7 6.1 ± 3.0 # 6.1 ± 3.0 #
Visceral Fat (g) 662.2 ± 207.6 641.6 ± 234.8 # 596.0 ± 229.8 *#† 686.3 ± 251.2 637.1 ± 261.4 628.9 ± 260.1 #
Visceral Fat Area (cm2) 125.1 ± 41.6 116.3 ± 49.4 107.6 ± 43.6 124.7 ± 51.0 112.4 ± 47.9 111.4 ± 47.1
Subcutaneous Fat (kg) 14.9 ± 3.4 13.8 ± 3.6 #† 13.5 ± 3.6 *#† 15.6 ± 4.3 14.8 ± 4.5 14.6 ± 4.5 #

# Indicates significant decrease from baseline (p < 0.05); * indicates significant difference in between groups in ITT analysis (p < 0.05); indicates significant difference between groups in PP analysis (p < 0.05); WC = waist circumference; HC = hip circumference; BMI = body mass index; FM = fat mass.